References
- Kempin S. J., Lee B. H., Thaler H. T., Koziner B., Hecht S., Gee T., Arlin Z., Little C., Strauss D., Reich L., Phillips E., Al-Mondhiry H., Dowling M., Mayer K., Clarkson B. Combination chemotherapy of advanced chronic lymphocytic leukemia—the M2 protocol. Blood 1982; 60: 1110–1115
- Hansen M. M., Anderson E., Christensen B. E., Christiansen I., Gisler C., Kristensen D., Jensen K. B., Junker P. CHOP versus prednisone and chlorambucil in CLL: Preliminary results of a randomized multicenter study. Nouv. Rev. Franc. Hematol. 1988; 30: 433–436
- Binet J. L. For the French Cooperative Group on CLL. CHOP regimen versus intermittent chlorambucil-prednisone in stage B, CLL. Short term results from a randomized clinical trial. Nouv. Rev. Franc. Hematol. 1988; 30: 449–452
- Cheson B. D. Current approaches to the chemotherapy of B-CLL chronic lymphocytic leukemia. A review. Amer. J. Hematol. 1989; 32: 72–77
- Bennett J. M., Raphael B., Oken M. M., Rubin Ph., Silber R. The prognosis and therapy of CLL under the age of 50 years. Nouv. Rev. Franc. Hematol. 1988; 30: 411–412
- De Rossi G., Mandelli R., Covelli A., Luciani M., Martelli M., Resegotti L., Alberti A., Cajozzo A., Deriu L., De Biasi R. Chronic lymphocytic leukemia (CLL) in younger adults: a retrospective study in 133 cases. Hematol. Oncol. 1989; 7: 127–137
- Lugassy G., Boussiotis V. A., Rochlemer R., Pangalis G. A., Berrebi A., Polliack A. Chronic lymphocytic leukemia in young adults: report of cases under the age of 30 and a review of therapeutic options. Leukemia and Lymphoma. 1991, (in press)
- Pangalis G. A., Roussou P., Kittas Ch., Mitsoulis-Mentzikof Ch., Matsouka-Alexandridis P., Anagnostopoulos N., Rombos I., Fessas Ph. Pattern of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well differentiated) non-Hodgkin's lymphoma. Cancer 1984; 54: 702–708
- Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol. 1989; 42: 567–584
- Binet J. L., Catovsky D., Chandra P., Dighiero G., Montserrat E., Rai K. P., Sawitsky A. Chronic lymphocytic leukemia: Proposals for a revised prognostic staging system. J. Haematol. 1981; 48: 365–367
- Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternak R. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
- Armitage P., Berry G. Statistical method in medical research 2nd ed. Blackwell Scientific publications, London 1987
- Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958; 53: 457–481
- Pangalis G. A., Roussou P. A., Kittas Ch., Kokkinou S., Fessas Ph. B-Chronic Lymphocytic Leukemia: Prognostic implication of Bone Marrow Histology in 120 Patients. Experience from a Single Hematology Unit. Cancer 1987; 59: 767–771
- Rozman C., Montserrat E., Rodriguez-Fernandez J. M., Ayats R., Vallespi T., Parody R., Rios A., Prados D., Morey M., Gomis F., Alcala A., Gutierrez M., Maldomado J., Gonzalez C., Giralt M., Hernandez-Nieto L., Cabrera A., Fernandez-Ranada J. M. Bone marrow histologic pattern: The best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases. Blood 1984; 64: 642–648
- Montserrat E., Sanchez-Bisono J., Vinolas N., Rozman C. Lymphocyte doubling time in chronic lymphocytic leukemia: Analysis of its prognostic significance. Br. J. Haematol. 1986; 62: 567–576
- Grever M. R., Leiby J. M., Kraut E. H., Wison H. E., Neidhart J. A., Wall R. L., Balcerzak S. P. Low-dose deoxycoformycin in lymphoid malignancy. J. Clin. Oncol. 1985; 3: 1196–1201
- Boussiotis V. A., Pangalis G. A. Randomized clinical trial with alpha-2b Interferon in 26 stage A untreated B-CLL patients. Nouv. Rev. Franc. Hematol. 1988; 30: 471–473
- Rozman C., Montserrat E., Vinolas N., Urbano-Ispizua A., Ribera J. M., Gallart T., Campenolle G. Recombinant alpha 2-Interferon in the treatment of chronic lymphocytic leukemia in early stages. Blood 1988; 71: 1295–1298
- Keating M. J., Kantarjian H., Talpaz M., Radman J., Koller C., Barlogie B., Velasquez W., Plunkett W., Freireich E. S., McCredie K. B. Fludarabine; a new agent with major activity against chronic lymphocytic leukemia. Blood 1989; 74: 19–25